JP2002538412A - てんかん素因の診断及び抗てんかん治療のモニタリング - Google Patents

てんかん素因の診断及び抗てんかん治療のモニタリング

Info

Publication number
JP2002538412A
JP2002538412A JP2000548720A JP2000548720A JP2002538412A JP 2002538412 A JP2002538412 A JP 2002538412A JP 2000548720 A JP2000548720 A JP 2000548720A JP 2000548720 A JP2000548720 A JP 2000548720A JP 2002538412 A JP2002538412 A JP 2002538412A
Authority
JP
Japan
Prior art keywords
epilepsy
kynurenine
metabolites
levels
rats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000548720A
Other languages
English (en)
Japanese (ja)
Inventor
スベットラナ ドリナ
アーロン ラビンコブ
ユージェネ プレスマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Neuroprotective Systems Ltd
Original Assignee
Advanced Neuroprotective Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Neuroprotective Systems Ltd filed Critical Advanced Neuroprotective Systems Ltd
Publication of JP2002538412A publication Critical patent/JP2002538412A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2857—Seizure disorders; Epilepsy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000548720A 1998-05-12 1999-05-12 てんかん素因の診断及び抗てんかん治療のモニタリング Pending JP2002538412A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12444498A IL124444A0 (en) 1998-05-12 1998-05-12 Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment
IL124444 1998-05-12
PCT/IL1999/000252 WO1999058968A1 (fr) 1998-05-12 1999-05-12 Diagnostic de la predisposition a l'epilepsie et surveillance de traitement anti-epileptique

Publications (1)

Publication Number Publication Date
JP2002538412A true JP2002538412A (ja) 2002-11-12

Family

ID=11071485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000548720A Pending JP2002538412A (ja) 1998-05-12 1999-05-12 てんかん素因の診断及び抗てんかん治療のモニタリング

Country Status (6)

Country Link
EP (1) EP1093580A4 (fr)
JP (1) JP2002538412A (fr)
AU (1) AU3727799A (fr)
CA (1) CA2332021A1 (fr)
IL (1) IL124444A0 (fr)
WO (1) WO1999058968A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021525865A (ja) * 2018-05-29 2021-09-27 エボゲン，インコーポレーテッド 非てんかん性発作／発作なし／心因性非てんかん性発作に対するてんかん性発作の評価および処置のためのバイオマーカーおよび方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003032894A2 (fr) * 2001-10-12 2003-04-24 Pfizer Products Inc. Methode de traitement neuroprotecteur de controle
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
GB201211120D0 (en) * 2012-06-22 2012-08-01 Bessede Alban Antagonist to an enzyme and/or a metabolite of the kynurenine pathway
GB201322538D0 (en) 2013-06-21 2014-02-05 Immusmol Sas Method for detecting small molecules in a sample
AU2013394569A1 (en) * 2013-07-18 2016-02-18 Dianti Ms Pty Limited Method and prognostic kit for monitoring multiple sclerosis (MS)
CN111886501A (zh) * 2018-03-19 2020-11-03 富士胶片和光纯药株式会社 精神疾病的判断方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021525865A (ja) * 2018-05-29 2021-09-27 エボゲン，インコーポレーテッド 非てんかん性発作／発作なし／心因性非てんかん性発作に対するてんかん性発作の評価および処置のためのバイオマーカーおよび方法

Also Published As

Publication number Publication date
EP1093580A1 (fr) 2001-04-25
CA2332021A1 (fr) 1999-11-18
AU3727799A (en) 1999-11-29
EP1093580A4 (fr) 2001-09-12
IL124444A0 (en) 1998-12-06
WO1999058968A1 (fr) 1999-11-18

Similar Documents

Publication Publication Date Title
Ferland et al. Deconstructing the neurobiology of cannabis use disorder
Samanta PCDH19-related epilepsy syndrome: a comprehensive clinical review
US7153692B2 (en) Diagnostic methods for determining susceptibility to convulsive conditions
Filser et al. Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions
Phillips et al. A de novo mutation in sporadic nocturnal frontal lobe epilepsy
Jin et al. CB1 cannabinoid receptor induction in experimental stroke
Hato et al. Ramsay Hunt syndrome in children
Maruyama et al. Novel mutations, pseudo‐dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism
US9034299B2 (en) ATF4 inhibitors and their use for neural protection, repair, regeneration, and plasticity
Noh et al. Clinical review of genetic epileptic encephalopathies
Peuchant et al. Infrared spectroscopy: a reagent-free method to distinguish Alzheimer's disease patients from normal-aging subjects
Xie et al. Relationship between inflammatory factors and arrhythmia and heart rate variability in OSAS patients.
JP2002538412A (ja) てんかん素因の診断及び抗てんかん治療のモニタリング
Mele et al. Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes
JP2003503083A (ja) アミロイド関連疾患の予防及び治療
JP2003504007A (ja) 神経変性性疾患における脳の特異的な領域での異なる遺伝子発現
Liu et al. New use for an old drug: quinidine in KCNT1-related epilepsy therapy
Yamamoto et al. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms
McLane et al. Peripheral amyloid precursor protein derivative expression in fragile X syndrome
Milh et al. Genetics of neonatal onset epilepsies: an overview
Grondin et al. Dopaminergic therapy improves upper limb motor performance in aged rhesus monkeys
Guerreiro et al. Elevated levels of BDNF and cathepsin‐d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I
WO2006021807A2 (fr) Methodes de diagnostic
Rogopoulos et al. Lumbar artery compression by the diaphragmatic crus: a new etiology for spinal cord ischemia
US7879568B2 (en) Method for the diagnosis and prognosis of demyelinating diseases

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060508

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090617

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090624

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090716

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090724

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090818

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090825

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091120